greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2025

Novartis AG (NVS) annual results, year to 31 December 2025: revenue USD 54,532 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2025 it reported revenue from the sale of goods of USD 54,532 million, up 8.4% on the year before. Its profit attributable to shareholders was USD 13,984 million, up 17.1%, and diluted earnings per share USD 7.15.

Revenue
USD 54,532 million
+8.4% on the year
FY2018FY2025
Operating margin
32.4%
28.9% a year earlier
FY2018FY2025
Net income
USD 13,984 million
+17.1% on the year
FY2018FY2025
Diluted EPS
USD 7.15
+21.8% on the year
FY2018FY2025

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2024Dec 2025
Revenue from the sale of goods50,31754,532
Cost of sales12,82713,699
Gross profit38,89542,975
Research and development10,02211,200
Selling, general and administrative12,56613,248
Operating profit14,54417,644
Profit before tax13,64016,352
Income tax1,7012,385
Profit for the year11,93913,967
Profit attributable to shareholders11,94113,984
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2024Dec 2025
Diluted EPS5.877.15
Basic EPS5.927.21
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2024Dec 2025
Cash from operations17,61919,144
Purchase of property, plant and equipment1,3661,548
Free cash flow16,25317,596
Cash from investing-7,513-4,877
Cash from financing-11,742-14,867
Buybacks8,3319,212
Dividends paid7,6247,818
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2024Dec 2025
Funded by
Equity attributable to shareholders44,04646,130
Non-controlling interests80.0419
Borrowings, as filed24,72228,729
Lease liabilities1,8031,920
Other liabilities31,59533,751
Total equity and liabilities102,246110,949
Owned
Property, plant and equipment9,45810,782
Goodwill24,75625,567
Other intangible assets26,91529,411
Cash and cash equivalents11,45911,435
Inventories5,7236,269
Other assets23,93527,485
Total assets102,246110,949
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2024Dec 2025
Return on year-end equity27.1%30.3%
Effective tax rate12.5%14.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2025, filed 4 February 2026: the filing. The figures are in US dollars as filed.